Verition Fund Management’s CorMedix CRMD Stock Holding History

Verition Fund Management’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-22,237	Closed	-$151K	–	2167
2026 Q1	$151K	Buy	+22,237	New	+$164K	﹤0.01%	1991
2025 Q3	–	Sell	-23,428	Closed	-$289K	–	3792
2025 Q2	$289K	Sell	23,428 -17,364	-43%	-$192K	﹤0.01%	3221
2025 Q1	$251K	Buy	+40,792	New	+$422K	﹤0.01%	2941
2024 Q3	–	Sell	-13,624	Closed	-$59K	–	3246
2024 Q2	$59K	Buy	+13,624	New	+$69.2K	﹤0.01%	2782
2023 Q4	–	Sell	-21,000	Closed	-$77.7K	–	2390
2023 Q3	$77.7K	Buy	+21,000	New	+$83.5K	﹤0.01%	2141
2019 Q2	–	Sell	-14,112	Closed	-$133K	–	1116
2019 Q1	$133K	Buy	+14,112	New	+$127K	0.01%	1006

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Verition Fund Management's CRMD Position: Q2 2026 in Review

Verition Fund Management sold out of CorMedix (CRMD) in Q2 2026, closing a stake of 22,237 shares — an estimated $151K sold.

Verition Fund Management first reported a position in CRMD in Q1 2019 and held it in 6 quarters. The position peaked at $289K in Q2 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Verition Fund Management reported no remaining CorMedix position as of Q2 2026 after selling out during the quarter.
Verition Fund Management sold 22,237 CorMedix shares in Q2 2026, an estimated $151K.
Verition Fund Management first reported a position in CorMedix in Q1 2019 and held it in 6 quarters.
Verition Fund Management's CorMedix position peaked at $289K in Q2 2025.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.